Central serous chorioretinopathy and risk of ischaemic stroke: A population-based cohort study

British Journal of Ophthalmology

Volumn 96, Issue 12, 2012, Pages 1484-1488

  Tsai, Der Chong ^a   Huang, Chin Chou ^a,b   Chen, Shih Jen ^b   Chou, Pesus ^a   Chung, Chia Min ^c   Chan, Wan Leong ^b   Huang, Po Hsun ^a,b   Chen, Tseng Ji ^a,b   Lin, Shing Jong ^a,b   Chen, Jaw Wen ^a,b   Leu, Hsin Bang ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CENTRAL SEROUS RETINOPATHY; CHRONIC DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOM SAMPLE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; TAIWAN;

ADOLESCENT; ADULT; AGED; BRAIN ISCHEMIA; CENTRAL SEROUS CHORIORETINOPATHY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TAIWAN; YOUNG ADULT;

EID: 84869884645     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-301810     Document Type: Article

References (34)

1. Kitzmann AS, Pulido JS, Diehl NN, et al. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology 2008;115:169-73.
2. Kitaya N, Nagaoka T, Hikichi T, et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 2003;87:709-12.
3. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Retina 1987;7:111-31.
4. Bouzas EA, Scott MH, Mastorakos G, et al. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 1993;111:1229-33.
5. Tittl MK, Spaide RF, Wong D, et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999;128:63-8.
6. Haimovici R, Koh S, Gagnon DR, et al. Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 2004;111:244-9.
7. Garg SP, Dada T, Talwar D, et al. Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 1997;81:962-4.
8. Sun J, Tan J, Wang Z, et al. Effect of catecholamine on central serous chorioretinopathy. J Huazhong Univ Sci Technolog Med Sci 2003;23:313-16.
9. Yoshioka H, Katsume Y, Akune H. Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings. Ophthalmologica 1982;185:168-78.
10. Tewari HK, Gadia R, Kumar D, et al. Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study. Invest Ophthalmol Vis Sci 2006;47:3474-8.
11. Thrall G, Lane D, Carroll D, et al. A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: implications for the pathogenesis of acute coronary syndromes. Thromb Res 2007;120:819-47.
12. Van Zaane B, Nur E, Squizzato A, et al. Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab 2009;94:2743-50.
13. Iijima H, Iida T, Murayama K, et al. Plasminogen activator inhibitor-1 in central serous chorioretinopathy. Am J Ophthalmol 1999;127:477-8.
14. Chien KL, Sung FC, Hsu HC, et al. Apolipoprotein A-I and B and stroke events in a community-based cohort in Taiwan: report of the Chin-Shan Community Cardiovascular Study. Stroke 2002;33:39-44.
15. Chen YC, Yeh HY, Wu JC, et al. Taiwan's National Health Insurance Research Database: administrative health care database as study object in bibliometrics. Scientometrics 2011;86:365-80.
16. Hu CC, Ho JD, Lin HC. Retinal vein occlusion and the risk of acute myocardial infarction: a 3-year follow-up study. Br J Ophthalmol 2009;93:717-20.
17. Chou KT, Huang CC, Tsai DC, et al. Sleep apnea and risk of retinal vein occlusion: a nationwide population-based study of Taiwanese. Am J Ophthalmol 2012;154:200-5.e1.
18. Hu CC, Ho JD, Lin HC. Neovascular age-related macular degeneration and the risk of stroke: a 5-year population-based follow-up study. Stroke 2010;41:613-17.
19. Chiang CH, Huang CC, Chan WL, et al. Association between Mycoplasma pneumoniae and increased risk of ischemic stroke: a nationwide study. Stroke 2011;42:2940-3.
20. Leu HB, Chung CM, Chuang SY, et al. Genetic variants of connexin37 are associated with carotid intima-medial thickness and future onset of ischemic stroke. Atherosclerosis 2011;214:101-6.
21. Cheng CL, Kao YH, Lin SJ, et al. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011;20:236-42.
22. Wang M, Munch IC, Hasler PW, et al. Central serous chorioretinopathy. Acta Ophthalmologica 2008;86:126-45.
23. Lee CS, Kang EC, Lee KS, et al. Central serous chorioretinopathy after renal transplantation. Retina 2011;31:1896-903.
24. Conrad R, Bodeewes I, Schilling G, et al. Chorioretinopathia centralis serosa und psychische Belastung. Ophthalmologe 2000;97:527-31.
25. Kornerup H, Osler M, Boysen G, et al. Major life events increase the risk of stroke but not of myocardial infarction: results from the Copenhagen City Heart Study. Eur J Cardiovasc Prev Rehabil 2010;17:113-18.
26. Levine SP, Towell BL, Suarez AM, et al. Platelet activation and secretion associated with emotional stress. Circulation 1985;71:1129-34.
27. Henry JP. Mechanisms by which stress can lead to coronary heart disease. Postgrad Med J 1986;62:687-93.
28. O'Brien AA, Rajkumar C, Bulpitt CJ. Blood pressure lowering for the primary and secondary prevention of stroke: treatment of hypertension reduces the risk of stroke. J Cardiovasc Risk 1999;6:203-5.
29. Haimovici R, Rumelt S, Melby J. Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 2003;110:698-703.
30. Dekkers OM, Biermasz NR, Pereira AM, et al. Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 2007;92:976-81.
31. Yamada R, Yamada S, Ishii A, et al. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy. Nippon GankaGakkai Zasshi 1993;97:955-60.
32. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005;294:1799-809.
33. Caccavale A, Imparato M, Romanazzi F, et al. A new strategy of treatment with low-dosage acetyl salicylic acid in patients affected by central serous chorioretinopathy. Med Hypotheses 2009;73:435-7.
34. Fantidis P. The role of the stress-related anti-inflammatory hormones ACTH and cortisol in atherosclerosis. Curr Vasc Pharmacol 2010;8:517-25.